Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy. - Nelson TA; Murthy NK; Martinez-Lage M; Abramson J; Branagan AR; Ji Y; Chen YA; Letourneau AR; Nahed BV; Arrillaga-Romany IC; Wang N; Dietrich J (Neurology, 2024)